Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2315

Jul 7, 2018

Scientists Use DNA And A Test Tube To Develop A.I. That May Be Capable Of Creating Its Own ‘Memories’

Posted by in categories: biotech/medical, robotics/AI

A new study by Caltech researchers has shown that the A.I. they created is fully capable of reading handwritten numbers.

Scientists have been able to create a completely artificial neural network by using DNA and a test tube, and the results of this AI experiment have been nothing short of astonishing.

During experiments, this artificial intelligence was able to accurately assess handwritten numbers, with scientists suggesting that this research shows that humans are edging ever closer to taking AI and placing it in organic circuits, as the Daily Mail reports.

Continue reading “Scientists Use DNA And A Test Tube To Develop A.I. That May Be Capable Of Creating Its Own ‘Memories’” »

Jul 7, 2018

HIV vaccine on horizon as jab triggers immunity in humans and stops monkeys being infected

Posted by in category: biotech/medical

A vaccine against HIV is on the horizon after scientists showed a new drug triggered a protective immune response in humans and stopped two thirds of monkeys becoming infected.

In the 35 years since the HIV epidemic began, just four vaccines have been tested on humans, with the best only lowering infection rates by 31 per cent, leading to trials being discontinued.

But in what was described as “promising” and “an important milestone”, an international team of scientists showed that the new vaccine boosted the immune systems of nearly 400 healthy adults.

Continue reading “HIV vaccine on horizon as jab triggers immunity in humans and stops monkeys being infected” »

Jul 7, 2018

Scientists discover a new mechanism that prevents the proliferation of cancer cells

Posted by in categories: biotech/medical, genetics

Canadian researchers have discovered a new and direct molecular mechanism to stop cancer cells from proliferating. In the prestigious journal Nature Cell Biology, scientists from Université de Montréal show that a disruption of a fine balance in the composition of ribosomes (huge molecules that translate the genetic code into proteins) results in a shutdown of cancer cell proliferation, triggering a process called senescence.

“Ribosomes are complex machines composed of both RNAs and proteins that make all the proteins necessary for to grow,” said UdeM biochemistry professor Gerardo Ferbeyre, the study’s senior author. Cancer cells grow and proliferate relentlessly and thus require a massive amount of ribosomes, he explained. Growing cells must coordinate the production of both ribosomal RNAs and ribosomal proteins in order to assemble them together in strict proportion to each other.

“We were surprised, however, to find that if the production of ribosomal RNA– proportions are driven out of balance in a cancer cell, proliferation can be shut down by in a very simple and direct manner,” said Ferbeyre.

Continue reading “Scientists discover a new mechanism that prevents the proliferation of cancer cells” »

Jul 7, 2018

Bioquark Inc. — WiseChase TV — Ira Pastor

Posted by in categories: aging, bioengineering, biological, biotech/medical, business, DNA, finance, futurism, genetics, health

https://wisechase.tv/the-bugs-that-reverse-damage/

Jul 7, 2018

Bioquark Inc. — Funky Thinkers Podcast — Ira Pastor

Posted by in categories: aging, bioengineering, biological, biotech/medical, DNA, futurism, genetics, health, life extension, transhumanism

https://www.youtube.com/watch?v=Nufc8vTsbBY

Jul 6, 2018

Longevity Film Competition

Posted by in categories: biotech/medical, life extension

ANNOUNCING THE LONGEVITY FILM COMPETITION

Please join in the crusade of eliminating age-related disease by making a video, and not only potentially help save lots of lives, but also win the first prize of $10,000! Second prize is a trip to meet Dr. Aubrey de Grey! This international (short) film competition is presented by the SENS Research Foundation, the International Longevity Alliance and Heales. The winning film will be chosen by our remarkable jury. For more information on how to compete and to sign up please visit www.longevityfilmcompetition.com

Read more

Jul 6, 2018

Neuroscientists Improve Memory Formation, Provide Hope for Alzheimer’s Patients

Posted by in categories: biotech/medical, neuroscience

The workings of memory and learning have yet to be clarified, especially at the neural circuitry level. But researchers at Uppsala University have now, jointly with Brazilian collaborators, discovered a specific brain neuron with a central role in learning. This study, published in Neuron, may have a bearing on the potential for counteracting memory loss in Alzheimer’s disease.

When a person with dementia forgets having just eaten dinner, it is due to hippocampus damage. In contrast, the same person can describe in vivid detail a fishing trip to Norway 40 years ago. Both cases entail the use of episodic memory, the brain’s storage of events in which we have been personally involved. Dementia diseases impair the ability to form new memories, especially of events since the onset of the disease.

Researchers at Uppsala University have now, jointly with Brazilian colleagues, found certain neurons in the brain that play a crucial part in learning. The same research group had previously discovered ‘gatekeeper cells’ or, in technical parlance, OLM (Oriens-lacunosum moleculare) cells. These are located in the hippocampus, the brain area known to be active in forming new memories. The new findings from Klas Kullander’s research group show that OLM cells’ activity affects the encoding of memories in the brain.

Continue reading “Neuroscientists Improve Memory Formation, Provide Hope for Alzheimer’s Patients” »

Jul 6, 2018

Menu: Whether or not you had a good life doesn’t make it any better if you die, of aging or other causes

Posted by in categories: biotech/medical, life extension

You’re probably familiar with the feeling of slight disappointment that you may have when a good thing—say, a nice trip—is over. Just as you say that it’s too bad that the experience is already finished, someone will probably say that you had a good time nonetheless; an innocent, fitting expression to cheer you up a little bit. This phrase can be harmlessly used in a variety of circumstances, but there’s one in which it really doesn’t fit at all, yet people keep using it: when somebody dies of aging.

Not quite the same thing

In the summer of 2011, my 99-year-old grandmother was dying. She was relatively fine one day, and then on the next day, for no apparent reason, she was in bed, barely conscious. Throughout the subsequent month, she never got out of bed; all her physical necessities were being taken care of by my aunt, who was assisting her day and night. She was drip-fed for the entire month until her death. The doctors couldn’t really do anything for her, and my aunt, stressed to her limit, was torn between the sight of the non-life her mother was going through and the thought that suspending the drip feed would possibly have been the more humane choice. The drip was never suspended, and eventually, my grandmother died.

Read more

Jul 6, 2018

A Single Cell Has The Power To Predict An Animal’s Lifespan

Posted by in category: biotech/medical

A new study published in the journal Cell Development reported that the size of an animal’s pancreatic cells relates directly to the length of its lifespan, with animals that have larger pancreatic cells living shorter lives and animals with smaller cells living longer.


Researchers studied the pancreases of 24 mammals in order to figure out how the organ grows, and what that means for an animal’s lifespan.

Read more

Jul 6, 2018

Survival of the Richest

Posted by in categories: 3D printing, biotech/medical, bitcoin, finance

Last year, I got invited to a super-deluxe private resort to deliver a keynote speech to what I assumed would be a hundred or so investment bankers. It was by far the largest fee I had ever been offered for a talk — about half my annual professor’s salary — all to deliver some insight on the subject of “the future of technology.”

I’ve never liked talking about the future. The Q&A sessions always end up more like parlor games, where I’m asked to opine on the latest technology buzzwords as if they were ticker symbols for potential investments: blockchain, 3D printing, CRISPR. The audiences are rarely interested in learning about these technologies or their potential impacts beyond the binary choice of whether or not to invest in them. But money talks, so I took the gig.

After I arrived, I was ushered into what I thought was the green room. But instead of being wired with a microphone or taken to a stage, I just sat there at a plain round table as my audience was brought to me: five super-wealthy guys — yes, all men — from the upper echelon of the hedge fund world. After a bit of small talk, I realized they had no interest in the information I had prepared about the future of technology. They had come with questions of their own.

Read more